Navigation Links
Brand Drug 'Copay Coupons' Undermine Generics, Raise Health Costs by $447 Million in Connecticut
Date:11/16/2011

WASHINGTON, Nov. 16, 2011 /PRNewswire-USNewswire/ -- The proliferation of brand drug "copay coupon" promotions, which lure insured consumers from generics to more expensive brands, will increase costs by $447 million in Connecticut over the next decade for employers, unions, and state employee plans, according to new research from Visante and released by the Pharmaceutical Care Management Association (PCMA).  The use of these promotions by state and local government workers alone will cost Connecticut taxpayers an extra $63 million over ten years.

Click here to read the study.

Unlike groceries and other goods that are purchased directly by consumers, 2/3 of prescription drug costs are paid by the employers, unions, and government agencies (i.e., taxpayers) that provide coverage, not consumers themselves.  Though banned as illegal kickbacks in federal health programs, copay coupons are unregulated in the commercial market (except Massachusetts).  

To minimize premiums and reduce costs, those who offer prescription drug coverage assign higher copays to expensive brands and lower copays to more affordable drugs that treat the same condition.  In response, drug companies now offer coupons that cover the higher copays but not the cost of the actual drug.  By covering a $50 copay to sell a $150 brand, drug companies extract an extra $100 from the employer, union, or government agency that offers coverage.  This helps explain why copay coupons target only those with insurance (i.e., those who pay copays), not the poor or uninsured.

"Brand copay coupons lure patients from generics to expensive brands and stick employers, unions, and government employee health programs with the extra costs," said PCMA President and CEO Mark Merritt.  "In Connecticut, taxpayers will pay an extra $63 million just to cover the use of brand copay coupons by government workers in state and municipal employee health programs."

Drug companies profit from coupon promotions in several ways:

  • Copay coupons induce consumers to choose higher-cost brands (despite higher copays) over lower-cost competitors (despite lower copays).  When consumers redeem copay coupons, the drug companies process them through a "shadow claims system" that prevents employers and other plan sponsors from knowing when enrollees have used them.
  • Drug companies often require consumers to submit confidential, personal information in order to redeem copay coupons.  Manufacturers have long sought (but found difficult to obtain) such sensitive patient data, which enables them to identify and directly target individual patients with "brand loyalty" marketing programs.

Coupons can also increase consumer costs in several ways:

  • To help cover the $4 billion spent annually on copay coupons nationally, manufacturers can simply raise prices.  Manufacturers reportedly earn a 4:1 to 6:1 return on investment (ROI) on copay coupon programs.
  • Copay coupons create "brand loyalty" to the most expensive products in each therapeutic class of drugs, even among newly diagnosed patients.


'/>"/>
SOURCE Pharmaceutical Care Management Association
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Brand Drug Copay Coupons Undermine Generics, Raise Health Costs by $2.1 Billion in Florida
2. Report: Brand Drug Copay Coupons Raise Health Costs for Employers, Unions, and State Governments by $32 Billion
3. UBM Live to Roll Out Pharma Contract Services & Outsourcing Brand in the US in 2012
4. Popular Sleep Supplement Brand Settles Patent Infringement Suit Against Store Brand Manufacturer
5. Prasco Named Exclusive U.S. Distributor for Selected Aspen Branded Products
6. A New Constant Companion: BodyMedia® Enlists Americas Toughest Trainer, Jillian Michaels, as a Brand Partner
7. DreamBrands New Formula Helps Men Feel Younger and Stronger While Naturally Raising Low-T Without Prescription Drugs
8. Octapharma Launches Clinical Trial to Evaluate Efficacy & Safety of wilate® In Preventing Surgical Bleeding in Type 3 von Willebrand Disease Patients
9. Why the Brand Surgical Institute in L.A. is Fast Becoming the Authority on Weight Loss Surgery
10. U.S. Branding Group Ltd. to Sponsor DigiPharm Europe 2011, Showcase PharmaDrive™ USB Insert™ Paper Webkey
11. IMD Announces the Acquisition of the Kidshape® Brand
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2017)... ... Research and Markets has announced the addition of the ... their offering. The global active pharmaceutical ingredients (API) ... by 2025. The rising prevalence of lifestyle-induced & age-related diseases and ... Advancements in recombinant molecular technologies and high capitalization for development of ...
(Date:2/28/2017)... Feb. 27, 2017  Titan Pharmaceuticals, Inc. (NASDAQ: ... treatment of select chronic diseases utilizing its ProNeura™ ... the U.S. Food & Drug Administration (FDA) has ... Investigational New Drug Application (IND) and has requested ... study pending submission of the requested information and ...
(Date:2/28/2017)... -- Medical robots market is projected to reach USD ... 2016, growing at a CAGR of 21.1% in the ... Read the full report: http://www.reportlinker.com/p04730562-summary/view-report.html ... advancements, increase in funding for medical robots research, issuance ... investments are the key factors driving the growth of ...
Breaking Medicine Technology:
(Date:2/28/2017)... ... , ... BrightStar Care Marietta announced that it has received the 2017 Best ... is granted only to top-ranking home care providers, based on client satisfaction scores gathered ... care providers from across the country who have proven their ability to provide the ...
(Date:2/27/2017)... ... February 27, 2017 , ... ... care industry, announces Chris Brandl as its New Guest Director. , Brandl ... to corporations throughout his career. He began his professional career at Omnium Worldwide, ...
(Date:2/27/2017)... Ohio (PRWEB) , ... February 27, 2017 , ... Elisa Guajardo Carothers is not your ... Life” to studying to become a nun. Now, she writes about God, when she isn’t ... “You Know BC and AD, Here is BS! (Before Satan),” she offers a comedic look ...
(Date:2/27/2017)... , ... February 27, 2017 , ... ... threshold mark last week. In addition, Discount Power's RCE (Residential Customer Equivalent) count ... in March 2014. The company had 800 customers and 2,250 RCEs at the ...
(Date:2/26/2017)... (PRWEB) , ... February 25, 2017 , ... The February ... Jong-un, heightened awareness and concern over nerve agents and the deadly use of chemical ... human nervous system and how even small doses can be lethal. , Jay Jagannathan, ...
Breaking Medicine News(10 mins):